Astellas Pharma Inc: all 983 studies
Page 8 of 10. Open to participants first (40), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy PatientsCompletedNCT01224028Phase 2
- Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) GeneCompletedNCT01221077Phase 2
- A Study to Evaluate the Effect of Oral Mirabegron on the Heart in Healthy Males and FemalesCompletedNCT01199523Phase 1
- Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal CancerCompletedNCT01197885Phase 2
- A Study to Evaluate the Drug Interaction of ASP015K and TacrolimusCompletedNCT01190670Phase 1
- A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941CompletedNCT01187186Phase 1
- Phase 2 Study of Maintenance OSI-906 Plus Erlotinib (Tarceva®), or Placebo Plus Erlotinib in Patients With Nonprogression Following 4 Cycles of Platinum-based ChemotherapyCompletedNCT01186861Phase 2
- A Study to Assess Drug Interaction of ASP015K and MidazolamCompletedNCT01182077Phase 1
- A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia PatientsCompletedNCT01181232Phase 4
- A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic PatientsCompletedNCT01135433Phase 3
- A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150 TabletCompletedNCT01125670Phase 1
- A Study to Compare the Pharmacokinetics of YM150 Formulation-A and Formulation-BCompletedNCT01125657Phase 1
- A Study to Assess the Systemic Disposition of ASP1585 After Administration of 14C-labeled DrugCompletedNCT01124747Phase 1
- A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to TreatmentCompletedNCT01122563
- Reproducibility Study of Overactive Bladder Symptom Score [OABSS]CompletedNCT01122550
- A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical SubjectsCompletedNCT01122368Phase 2
- A Study to Assess Safety and Tolerability of ASP1941 After Single and Repeated Administration in Healthy SubjectsCompletedNCT01121198Phase 1
- A Study to Verify the Efficacy of YM177 (Celecoxib) in Postoperative Pain PatientsCompletedNCT01118572Phase 3
- A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150CompletedNCT01118559Phase 1
- A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes MellitusCompletedNCT01117584Phase 2
- A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy VolunteersCompletedNCT01115985Phase 1
- A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy VolunteersCompletedNCT01115972Phase 1
- A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Enalapril in Healthy VolunteersCompletedNCT01115946Phase 1
- A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney CancerCompletedNCT01114230Phase 1
- A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Sitagliptin When Given Together to Healthy SubjectsCompletedNCT01104532Phase 1
- A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCCTerminatedNCT01101906Phase 2
- A Study to Assess Drug-Drug Interaction Between ASP1941 and MiglitolCompletedNCT01099839Phase 1
- A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)TerminatedNCT01099345
- A Study to Assess the Pharmacokinetics, Pharmacodynamics of ASP1941 in Diabetes Mellitus Patients With Renal ImpairmentCompletedNCT01097681Phase 1
- A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe PsoriasisCompletedNCT01096862Phase 2
- A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Pioglitazone Hydrochloride When Given Together to Healthy SubjectsCompletedNCT01088919Phase 1
- ASP1517 Pharmacokinetics Study in Anemia Patients on HemodialysisCompletedNCT01083888Phase 1
- A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes MellitusCompletedNCT01071850Phase 2
- Liver Transplant European Study Into the Prevention of Fungal InfectionCompletedNCT01058174Phase 3
- A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes PatientsCompletedNCT01057628Phase 3
- A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on HemodialysisCompletedNCT01057407Phase 3
- A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic PatientsCompletedNCT01054092Phase 3
- A Study of YM178 in Subjects With Symptoms of Overactive BladderCompletedNCT01043666Phase 3
- A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast CancerCompletedNCT01038804Phase 2
- Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal SubjectsCompletedNCT01029015
- YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical IllnessCompletedNCT01028950Phase 3
- A Study of ASP1941 in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT01023945Phase 1
- A Clinical Pharmacological Study of YM155 After Intravenous Infusion in Patients With Advanced CancerCompletedNCT01023386Phase 1
- A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation PatientsCompletedNCT01018914Phase 4
- A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal DialysisCompletedNCT01017276Phase 3
- A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian CancerTerminatedNCT01016054Phase 1
- Relative Bioavailability Study of Solifenacin Succinate Liquid Suspension (Fed and Fasting) Versus VESIcare Tablet (Fasting) in Healthy VolunteersCompletedNCT01015040Phase 1
- Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver TransplantationCompletedNCT01011205Phase 3
- Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic CancerCompletedNCT01010945Phase 1
- A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV MelanomaCompletedNCT01009775Phase 2
- A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior TreatmentCompletedNCT01007292Phase 2
- A Study of FK199B to Compare Efficacy With Zolpidem by Polysomnography in Patients With InsomniaCompletedNCT00999219Phase 3
- Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary SyndromesCompletedNCT00994292Phase 2
- Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder PatientsCompletedNCT00985387
- Safety, Tolerability and Pharmacokinetic Study of ASP1517 in Healthy Non-elderly Male VolunteersCompletedNCT00978198Phase 1
- A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive BladderCompletedNCT00966004Phase 3
- A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent FormulationCompletedNCT00965978Phase 1
- A Study to Investigate the Food Effect on the Pharmacokinetics of YM178 in Healthy, Non-elderly VolunteersCompletedNCT00965926Phase 1
- A Study to Evaluate Efficacy and Safety of Zolpidem Modified Release Formulation in Insomnia PatientsCompletedNCT00956319Phase 4
- A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular DegenerationCompletedNCT00950638Phase 1
- A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal SurgeryCompletedNCT00942435Phase 3
- Pharmacokinetics of Oral Mirabegron With Different Release Rates Versus Intravenous (IV) MirabegronCompletedNCT00940121Phase 1
- Study of the Effect of Food on the Pharmacokinetics of MirabegronCompletedNCT00939757Phase 1
- A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial FibrillationCompletedNCT00938730Phase 2
- Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower ExtremitiesCompletedNCT00937911Phase 3
- Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous ThromboembolismCompletedNCT00937820Phase 3
- Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal AllograftsCompletedNCT00933231Phase 3
- A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical CarcinomaCompletedNCT00924989Phase 3
- Effect of Food Intake on Pharmacokinetic Profiles of Z-338CompletedNCT00920998Phase 1
- A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel SyndromeCompletedNCT00918411Phase 4
- Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement SurgeryCompletedNCT00917254Phase 2/3
- Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement SurgeryCompletedNCT00913120Phase 2/3
- Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release TacrolimusCompletedNCT00909571Phase 3
- Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal CancerCompletedNCT00909025Phase 1
- Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community ClinicsCompletedNCT00902980
- A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement SurgeryCompletedNCT00902928Phase 2/3
- A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic CancerCompletedNCT00902291Phase 2
- Reproducibility Study of Over Active Bladder Symptom Score [OABSS]CompletedNCT00901251
- Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on HemodialysisCompletedNCT00892749Phase 3
- A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)CompletedNCT00889382Phase 1/2
- Benefit of Early Protocol Biopsy and Treatment of Subclinical RejectionCompletedNCT00885820Phase 4
- Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy VolunteersTerminatedNCT00870441Phase 1
- An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant RecipientsCompletedNCT00865137Phase 3
- A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy SubjectsCompletedNCT00856570Phase 1
- A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy AdultsCompletedNCT00850746Phase 1
- A Long-term Study of YM178 in Symptomatic Overactive Bladder PatientsCompletedNCT00840645Phase 3
- An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in NeonatesCompletedNCT00818584Phase 1
- An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155CompletedNCT00818480Phase 2
- Comparison of Extended Release Tacrolimus (Advagraf) and Cyclosporine A Microemulsion on Renal Function in Healthy VolunteersCompletedNCT00818194Phase 1
- A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian CancerCompletedNCT00816764Phase 1
- A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell CancerTerminatedNCT00816686Phase 1
- Retrospective, Non-interventional Study of Depo-Eligard®.CompletedNCT00811876
- Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe PsoriasisCompletedNCT00808223Phase 2
- Solifenacin Succinate Versus Tolterodine 4mg Once DailyCompletedNCT00802373Phase 3
- Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic DermatitisCompletedNCT00801957Phase 2
- Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency SymptomsCompletedNCT00801944Phase 3
- Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque PsoriasisTerminatedNCT00795353
- A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal InfectionsCompletedNCT00794703Phase 3
- ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis PatientsCompletedNCT00794443Phase 2/3
- A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.CompletedNCT00790660Phase 2